215 related articles for article (PubMed ID: 17549010)
1. Identification of novel biomarkers in pediatric primitive neuroectodermal tumors and ependymomas by proteome-wide analysis.
de Bont JM; den Boer ML; Kros JM; Passier MM; Reddingius RE; Smitt PA; Luider TM; Pieters R
J Neuropathol Exp Neurol; 2007 Jun; 66(6):505-16. PubMed ID: 17549010
[TBL] [Abstract][Full Text] [Related]
2. Identification of novel nasopharyngeal carcinoma biomarkers by laser capture microdissection and proteomic analysis.
Cheng AL; Huang WG; Chen ZC; Peng F; Zhang PF; Li MY; Li F; Li JL; Li C; Yi H; Yi B; Xiao ZQ
Clin Cancer Res; 2008 Jan; 14(2):435-45. PubMed ID: 18223218
[TBL] [Abstract][Full Text] [Related]
3. Molecular markers of primitive neuroectodermal tumors and other pediatric central nervous system tumors. Monoclonal antibodies to neuronal and glial antigens distinguish subsets of primitive neuroectodermal tumors.
Molenaar WM; Jansson DS; Gould VE; Rorke LB; Franke WW; Lee VM; Packer RJ; Trojanowski JQ
Lab Invest; 1989 Dec; 61(6):635-43. PubMed ID: 2557487
[TBL] [Abstract][Full Text] [Related]
4. Sensitivity and specificity of epithelial membrane antigen staining patterns in ependymomas.
Hasselblatt M; Paulus W
Acta Neuropathol; 2003 Oct; 106(4):385-8. PubMed ID: 12898159
[TBL] [Abstract][Full Text] [Related]
5. Proteomic analysis of the human receptive versus non-receptive endometrium using differential in-gel electrophoresis and MALDI-MS unveils stathmin 1 and annexin A2 as differentially regulated.
Domínguez F; Garrido-Gómez T; López JA; Camafeita E; Quiñonero A; Pellicer A; Simón C
Hum Reprod; 2009 Oct; 24(10):2607-17. PubMed ID: 19556289
[TBL] [Abstract][Full Text] [Related]
6. Glial differentiation predicts poor clinical outcome in primitive neuroectodermal brain tumors.
Janss AJ; Yachnis AT; Silber JH; Trojanowski JQ; Lee VM; Sutton LN; Perilongo G; Rorke LB; Phillips PC
Ann Neurol; 1996 Apr; 39(4):481-9. PubMed ID: 8619526
[TBL] [Abstract][Full Text] [Related]
7. Novel breast cancer biomarkers identified by integrative proteomic and gene expression mapping.
Ou K; Yu K; Kesuma D; Hooi M; Huang N; Chen W; Lee SY; Goh XP; Tan LK; Liu J; Soon SY; Bin Abdul Rashid S; Putti TC; Jikuya H; Ichikawa T; Nishimura O; Salto-Tellez M; Tan P
J Proteome Res; 2008 Apr; 7(4):1518-28. PubMed ID: 18318472
[TBL] [Abstract][Full Text] [Related]
8. [Diagnostic use of D2-40 and annexin-1 in ependymal tumors].
Wang YF; Piao YS; Lu DH; Chen L; Wang W; Yang H; Wei LF
Zhonghua Bing Li Xue Za Zhi; 2011 Sep; 40(9):595-8. PubMed ID: 22177242
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of cyclooxygenase-2 in childhood ependymomas: role of COX-2 inhibitor in growth and multi-drug resistance in vitro.
Kim SK; Lim SY; Wang KC; Kim YY; Chi JG; Choi YL; Shin HJ; Cho BK
Oncol Rep; 2004 Aug; 12(2):403-9. PubMed ID: 15254709
[TBL] [Abstract][Full Text] [Related]
10. Neurotrophin receptor TrkC predicts good clinical outcome in medulloblastoma and other primitive neuroectodermal brain tumors.
Grotzer MA; Janss AJ; Phillips PC; Trojanowski JQ
Klin Padiatr; 2000; 212(4):196-9. PubMed ID: 10994550
[TBL] [Abstract][Full Text] [Related]
11. Chlorotoxin, a scorpion-derived peptide, specifically binds to gliomas and tumors of neuroectodermal origin.
Lyons SA; O'Neal J; Sontheimer H
Glia; 2002 Aug; 39(2):162-73. PubMed ID: 12112367
[TBL] [Abstract][Full Text] [Related]
12. Expression of neurogenic basic helix-loop-helix genes in primitive neuroectodermal tumors.
Rostomily RC; Bermingham-McDonogh O; Berger MS; Tapscott SJ; Reh TA; Olson JM
Cancer Res; 1997 Aug; 57(16):3526-31. PubMed ID: 9270024
[TBL] [Abstract][Full Text] [Related]
13. Expression of alpha-, beta-, and gamma-synuclein in glial tumors and medulloblastomas.
Fung KM; Rorke LB; Giasson B; Lee VM; Trojanowski JQ
Acta Neuropathol; 2003 Aug; 106(2):167-75. PubMed ID: 12783249
[TBL] [Abstract][Full Text] [Related]
14. Shared molecular targets in pediatric gliomas and ependymomas.
Tsuruta T; Aihara Y; Kanno H; Funase M; Murayama T; Osawa M; Fujii H; Kubo O; Okada Y
Pediatr Blood Cancer; 2011 Dec; 57(7):1117-23. PubMed ID: 21298772
[TBL] [Abstract][Full Text] [Related]
15. Ependymomas of the central nervous system and adult extra-axial ependymomas are morphologically and immunohistochemically distinct--a comparative study with assessment of ovarian carcinomas for expression of glial fibrillary acidic protein.
Idowu MO; Rosenblum MK; Wei XJ; Edgar MA; Soslow RA
Am J Surg Pathol; 2008 May; 32(5):710-8. PubMed ID: 18360284
[TBL] [Abstract][Full Text] [Related]
16. Pediatric ependymoma: biological perspectives.
Kilday JP; Rahman R; Dyer S; Ridley L; Lowe J; Coyle B; Grundy R
Mol Cancer Res; 2009 Jun; 7(6):765-86. PubMed ID: 19531565
[TBL] [Abstract][Full Text] [Related]
17. Decreased expression of Annexin A1 correlates with pathologic differentiation grade in oral squamous cell carcinoma.
Zhang L; Yang X; Zhong LP; Zhou XJ; Pan HY; Wei KJ; Li J; Chen WT; Zhang ZY
J Oral Pathol Med; 2009 Apr; 38(4):362-70. PubMed ID: 18673418
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of Ki-67 (MIB-1) proliferation index in childhood primitive neuroectodermal tumors of the central nervous system.
Grotzer MA; Geoerger B; Janss AJ; Zhao H; Rorke LB; Phillips PC
Med Pediatr Oncol; 2001 Feb; 36(2):268-73. PubMed ID: 11452934
[TBL] [Abstract][Full Text] [Related]
19. Expression of the Neural RNA-binding protein Musashi1 in pediatric brain tumors.
Nakano A; Kanemura Y; Mori K; Kodama E; Yamamoto A; Sakamoto H; Nakamura Y; Okano H; Yamasaki M; Arita N
Pediatr Neurosurg; 2007; 43(4):279-84. PubMed ID: 17627143
[TBL] [Abstract][Full Text] [Related]
20. Differential involvement of protein 4.1 family members DAL-1 and NF2 in intracranial and intraspinal ependymomas.
Singh PK; Gutmann DH; Fuller CE; Newsham IF; Perry A
Mod Pathol; 2002 May; 15(5):526-31. PubMed ID: 12011257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
